Nasdaq:XENE

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 02, 2025 16:42 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE)…

7 hours ago
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

April 04, 2025 08:30 ET  | Source: Xenon Pharmaceuticals Inc. Three epilepsy posters to be presented in scientific sessions at…

4 weeks ago